Literature DB >> 31282286

An integrative sparse boosting analysis of cancer genomic commonality and difference.

Yifan Sun1, Zhengyang Sun1, Yu Jiang2, Yang Li1, Shuangge Ma1,3.   

Abstract

In cancer research, high-throughput profiling has been extensively conducted. In recent studies, the integrative analysis of data on multiple cancer patient groups/subgroups has been conducted. Such analysis has the potential to reveal the genomic commonality as well as difference across groups/subgroups. However, in the existing literature, methods with a special attention to the genomic commonality and difference are very limited. In this study, a novel estimation and marker selection method based on the sparse boosting technique is developed to address the commonality/difference problem. In terms of technical innovation, a new penalty and computation of increments are introduced. The proposed method can also effectively accommodate the grouping structure of covariates. Simulation shows that it can outperform direct competitors under a wide spectrum of settings. The analysis of two TCGA (The Cancer Genome Atlas) datasets is conducted, showing that the proposed analysis can identify markers with important biological implications and have satisfactory prediction and stability.

Entities:  

Keywords:  Integrative analysis; cancer genomics; commonality and difference; sparse boosting

Mesh:

Year:  2019        PMID: 31282286      PMCID: PMC7471599          DOI: 10.1177/0962280219859026

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  30 in total

1.  Extracting the multiscale backbone of complex weighted networks.

Authors:  M Angeles Serrano; Marián Boguñá; Alessandro Vespignani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-08       Impact factor: 11.205

2.  Identification of cancer omics commonality and difference via community fusion.

Authors:  Yifan Sun; Yu Jiang; Yang Li; Shuangge Ma
Journal:  Stat Med       Date:  2018-11-12       Impact factor: 2.373

Review 3.  Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Authors:  Pankaj Dwivedi; Kenneth D Greis
Journal:  Exp Hematol       Date:  2016-10-24       Impact factor: 3.084

4.  Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.

Authors:  De-Gang Liu; Lei Xue; Jun Li; Qiang Yang; Jiang-Zhou Peng
Journal:  Cancer Biomark       Date:  2018       Impact factor: 4.388

5.  Targeting cell division cycle 25 homolog B to regulate influenza virus replication.

Authors:  Olivia Perwitasari; Ana Claudia Torrecilhas; Xiuzhen Yan; Scott Johnson; Caleb White; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

6.  A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.

Authors:  Paola Moreno; Samuel A Mantey; Suk H Lee; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Peptides       Date:  2018-02-02       Impact factor: 3.750

7.  CEP89 is required for mitochondrial metabolism and neuronal function in man and fly.

Authors:  Bregje W M van Bon; Merel A W Oortveld; Leo G Nijtmans; Michaela Fenckova; Bonnie Nijhof; Judith Besseling; Melissa Vos; Jamie M Kramer; Nicole de Leeuw; Anna Castells-Nobau; Lenke Asztalos; Erika Viragh; Mariken Ruiter; Falko Hofmann; Lillian Eshuis; Licio Collavin; Martijn A Huynen; Zoltan Asztalos; Patrik Verstreken; Richard J Rodenburg; Jan A Smeitink; Bert B A de Vries; Annette Schenck
Journal:  Hum Mol Genet       Date:  2013-04-10       Impact factor: 6.150

8.  Gene network-based cancer prognosis analysis with sparse boosting.

Authors:  Shuangge Ma; Yuan Huang; Jian Huang; Kuangnan Fang
Journal:  Genet Res (Camb)       Date:  2012-08       Impact factor: 1.588

9.  Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas.

Authors:  Larsson Omberg; Kyle Ellrott; Yuan Yuan; Cyriac Kandoth; Chris Wong; Michael R Kellen; Stephen H Friend; Josh Stuart; Han Liang; Adam A Margolin
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

10.  Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia.

Authors:  Mina Ebrahimi-Rad; Shohreh Khatami; Shahla Ansari; Shohreh Jalylfar; Shirin Valadbeigi; Reza Saghiri
Journal:  J Med Biochem       Date:  2018-04-01       Impact factor: 3.402

View more
  1 in total

1.  Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.

Authors:  Sanguo Zhang; Xiaonan Hu; Ziye Luo; Yu Jiang; Yifan Sun; Shuangge Ma
Journal:  Stat Med       Date:  2021-04-27       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.